Allianz Asset Management’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
VPM
VCM
AIM
Allianz Asset Management's VCYT Position: Q1 2026 in Review
Allianz Asset Management increased its Veracyte (VCYT) stake by 17% in Q1 2026, buying an estimated $858K and bringing the position to 158,871 shares worth $5.12M. The position accounts for 0.01% of the portfolio, ranked #1150.
Allianz Asset Management first reported a position in VCYT in Q2 2018 and has held it in 19 quarters since. The position peaked at $14.5M in Q1 2019. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.
- Allianz Asset Management held 158,871 shares of Veracyte worth $5.12M as of Q1 2026.
- Allianz Asset Management bought 23,185 Veracyte shares in Q1 2026, an estimated $858K.
- Veracyte made up 0.01% of Allianz Asset Management's portfolio in Q1 2026, its #1150 holding.
- Allianz Asset Management first reported a position in Veracyte in Q2 2018 and has held it in 19 quarters since.
- Allianz Asset Management's Veracyte position peaked at $14.5M in Q1 2019.
- 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.
Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.